Company profile
Employees
SEC CIK
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
16 May 22
DFAN14A
Additional proxy materials by non-management
12 May 22
DFAN14A
Additional proxy materials by non-management
5 May 22
DFAN14A
Additional proxy materials by non-management
4 May 22
DFAN14A
Additional proxy materials by non-management
2 May 22
DFAN14A
Additional proxy materials by non-management
27 Apr 22
DFAN14A
Additional proxy materials by non-management
25 Apr 22
DFAN14A
Additional proxy materials by non-management
22 Apr 22
DFAN14A
Additional proxy materials by non-management
13 Apr 22
DFAN14A
Additional proxy materials by non-management
11 Apr 22
Latest ownership filings
4
Eiger BioPharmaceuticals, Inc.
2 Nov 23
3
Eiger BioPharmaceuticals, Inc.
30 Oct 23
SC 13G
Athira Pharma, Inc.
20 Apr 23
4
Altus Midstream Co
28 Jun 19
4
Kimbell Royalty Partners, LP
3 May 19
4
Kimbell Royalty Partners, LP
12 Apr 19
4
Altus Midstream Co
27 Mar 19
4
Altus Midstream Co
13 Mar 19
4/A
Altus Midstream Co
4 Mar 19
4/A
Altus Midstream Co
27 Dec 18
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Nov 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2977 | 23,398 | 6.97 k | 5,375,225 |
1 Nov 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2797 | 100,000 | 27.97 k | 5,351,827 |
31 Oct 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2414 | 130,509 | 31.50 k | 5,251,827 |
31 Oct 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2615 | 12,345 | 3.23 k | 5,121,318 |
31 Oct 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2625 | 11,987 | 3.15 k | 5,108,973 |